CompletedNot Applicable

Comparing Efficacy of Optimal Treatment and Conventional Treatment for Major Depressive Disorder in Viet Nam

Vietnam171 participantsStarted 2021-03-01

Plain-language summary

Comparison of efficacy treatment (respond, remission) between the optimized treatment group (dose adjustment or early change other drug based on the change of total score HAM-D 17) and the routine treatment group (start with the lowest effective dose and adjust dose slowly) for depressed patients in Viet Nam

Who can participate

Age range18 Years

SexALL

See this in plain English?

AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.

Inclusion Criteria: * New or first recurrent diagnosed as major depression disorder. * Having total score HAM-D 17 ≥ 17 point Exclusion Criteria: * Can not answer the question in HAM-D 17 * Having psychosis, anxiety disorder, obsessive-compulsive disorder * Having risk of suicide now or 3 months past * having medical history: diabetes mellitus, hypothyroidism, hypopituitarism, epilepsy, renal failure, heart failure, stroke, myocardial infarction, liver failure, cirrhosis. * Pregnancy

What they're measuring

Comparison of rate of respond patient between optimization and routine treatment group

Timeframe: 8 weeks

Trial details

NCT IDNCT04826614

SponsorUniversity of Medicine and Pharmacy at Ho Chi Minh City

Sponsor typeOTHER

Study typeINTERVENTIONAL

Primary completion2022-07-30

View on ClinicalTrials.gov More Major Depressive Disorder trials